Evidence map›Paper›PMID 37323377›Full record

ArticleACS omega2023

NRPreTo: A Machine Learning-Based Nuclear Receptor and Subfamily Prediction Tool.

Sita Sirisha Madugula, Suman Pandey, Shreya Amalapurapu, Serdar Bozdag

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sita Sirisha MadugulaDepartment of Computer Science & Engineering, University of North Texas, Denton, Texas TX 76203, United States.
Suman PandeyDepartment of Computer Science & Engineering, University of North Texas, Denton, Texas TX 76203, United States.
Shreya AmalapurapuDepartment of Computer Science & Engineering, University of North Texas, Denton, Texas TX 76203, United States.
Serdar BozdagDepartment of Computer Science & Engineering, University of North Texas, Denton, Texas TX 76203, United States.ORCID https://orcid.org/0000-0002-4813-4310
University of North Texas · US

Funding

lntegrating multi-omics datasets to infer phenotype-specific driver genes, regulatory interactions and drug responseR35GM133657 · NIGMS · UNIVERSITY OF NORTH TEXAS · PI Serdar Bozdag · 2019 to 2026
$3.1M
NIGMS NIH HHS R35 GM133657
6 · The paper itself

Abstract

The nuclear receptor (NR) superfamily includes phylogenetically related ligand-activated proteins, which play a key role in various cellular activities. NR proteins are subdivided into seven subfamilies based on their function, mechanism, and nature of the interacting ligand. Developing robust tools to identify NR could give insights into their functional relationships and involvement in disease pathways. Existing NR prediction tools only use a few types of sequence-based features and are tested on relatively similar independent datasets; thus, they may suffer from overfitting when extended to new genera of sequences. To address this problem, we developed Nuclear Receptor Prediction Tool (NRPreTo), a two-level NR prediction tool with a unique training approach where in addition to the sequence-based features used by existing NR prediction tools, six additional feature groups depicting various physiochemical, structural, and evolutionary features of proteins were utilized. The first level of NRPreTo allows for the successful prediction of a query protein as NR or non-NR and further subclassifies the protein into one of the seven NR subfamilies in the second level. We developed Random Forest classifiers to test on benchmark datasets, as well as the entire human protein datasets from RefSeq and Human Protein Reference Database (HPRD). We observed that using additional feature groups improved the performance. We also observed that NRPreTo achieved high performance on the external datasets and predicted 59 novel NRs in the human proteome. The source code of NRPreTo is publicly available at https://github.com/bozdaglab/NRPreTo.

Identifiers

PMID37323377
PMCPMC10268018
OpenAlexW4380866389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.